News Sentiment

ASMB sentiment intelligence

Assembly Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 27.40 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-1.2% over one week, +19.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Enterprise value to EBIT forward of Assembly Biosciences, Inc. – NASDAQ:ASMB

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction -1.2% Price digesting
Trend fit Trend inactive 19.3% over four weeks
Fair value 50.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 45
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
TradingView 9
Stock Titan 8
simplywall.st 6
TradingKey 5
Stock Traders Daily 3
marketscreener.com 3
GlobeNewswire 3

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 18
Analyst action 3
Balance sheet 2
Deals and strategy 1
Guidance 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 63
TradingView Direct company coverage

Enterprise value to EBIT forward of Assembly Biosciences, Inc. – NASDAQ:ASMB

The article provides a financial overview of Assembly Biosciences, Inc. (NASDAQ: ASMB), focusing on its enterprise value to EBIT forward. It primarily presents the title and basic identification of the company within a financial data platform. The content primarily consists of na

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 22:42
Source
TradingView
Stock Traders Daily Direct company coverage

Avoiding Lag: Real-Time Signals in (ASMB) Movement

This article provides an AI-generated analysis of Assembly Biosciences Inc. (NASDAQ: ASMB), noting a near-term neutral sentiment amidst mid and long-term strength. It highlights a significant 65.7:1 risk-reward short setup and outlines three institutional trading strategies: a lo

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 18:40
Source
Stock Traders Daily
TradingView Direct company coverage

Enterprise value to EBIT forward of Assembly Biosciences, Inc. – HAM:V7B

This article focuses on the enterprise value to EBIT forward ratio for Assembly Biosciences, Inc. (HAM:V7B) on the Hamburg Stock Exchange. It appears to be a financial data page from TradingView, providing an overview of the company's financials without offering specific numerica

Tone
Neutral 50/100
Event
Market update
Published
10 Jul 2026 05:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Assembly Biosciences, Inc. – FWB:V7B

This article displays information regarding the price to earnings forward of Assembly Biosciences, Inc. (FWB:V7B) on the Frankfurt Stock Exchange. It notes that the market is currently closed with no trades. The article is part of TradingView's financial data offerings.

Tone
Neutral 50/100
Event
Earnings
Published
09 Jul 2026 18:42
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Assembly Biosciences, Inc. – NASDAQ:ASMB

This article provides a brief snapshot of the Enterprise Value to Revenue (Forward) for Assembly Biosciences, Inc. (NASDAQ: ASMB) as presented on TradingView. It highlights key financial metrics and navigational elements related to the company's profile on the platform. The conte

Tone
Neutral 50/100
Event
Earnings
Published
08 Jul 2026 11:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Assembly Biosciences, Inc. – NASDAQ:ASMB

This article focuses on the enterprise value to EBITDA forward metric for Assembly Biosciences, Inc. (NASDAQ: ASMB). It indicates that the company's financial data is available for review, likely on the TradingView platform. The content primarily serves as a placeholder for detai

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 06:39
Source
TradingView
TradingView Direct company coverage

Price to book forward of Assembly Biosciences, Inc. – NASDAQ:ASMB

This article provides a financial snapshot for Assembly Biosciences, Inc. (NASDAQ: ASMB), focusing on its price to book forward metric. It appears to be a stub or an incomplete data entry from TradingView, lacking detailed financial figures but highlighting the company within the

Tone
Neutral 50/100
Event
Market update
Published
05 Jul 2026 21:11
Source
TradingView
Finviz Direct company coverage

ASMB - Assembly Biosciences Inc Options

This article provides a detailed financial overview of Assembly Biosciences Inc. (ASMB), including its current stock performance, key financial metrics, analyst ratings, and insider transaction data. It highlights the company's valuation, profitability, growth rates, and market i

Tone
Neutral 50/100
Event
Analyst action
Published
02 Jul 2026 22:09
Source
Finviz
Stock Traders Daily Direct company coverage

Discipline and Rules-Based Execution in ASMB Response

This article provides an in-depth analysis of Assembly Biosciences Inc. (NASDAQ: ASMB), highlighting strong sentiment across all horizons and identifying a mid-channel oscillation pattern. It presents three AI-generated institutional trading strategies—Position Trading, Momentum

Tone
Positive 75/100
Event
Market update
Published
30 Jun 2026 17:08
Source
Stock Traders Daily
marketscreener.com Direct company coverage

Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2500 Index

Assembly Biosciences, Inc. (NasdaqGS: ASMB), a biotechnology company focused on developing therapies for serious viral diseases, has been added to the Russell 2500 Index. This inclusion is one of several recent adjustments for the company across various Russell indices, including

Tone
Positive 71/100
Event
Market update
Published
29 Jun 2026 13:11
Source
marketscreener.com
TradingView Direct company coverage

Assembly Biosciences, Inc. Actuals & Estimates (NASDAQ:ASMB)

This article provides an overview of Assembly Biosciences, Inc. (NASDAQ: ASMB) stock, including its current price, market capitalization, and historical performance. It details analyst forecasts, past earnings reports, and upcoming financial dates, such as the next earnings relea

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 05:40
Source
TradingView
TradingView Direct company coverage

ASMB Forecast — Price Target — Prediction for 2027

This article provides a forecast for Assembly Biosciences, Inc. (ASMB) stock, including analyst price targets, historical performance data, and financial metrics. Four analysts have provided 1-year price forecasts, with estimates ranging from $43.00 to $62.00. The company's stock

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 20:09
Source
TradingView
TradingKey Direct company coverage

Assembly Biosciences Inc (ASMB) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Assembly Biosciences Inc (ASMB), detailing its current price momentum score, support and resistance levels. It includes a review of various technical indicators like MACD, RSI, and moving averages, offering "Sell," "Neutral," or "Buy"

Tone
Negative 29/100
Event
Market update
Published
24 Jun 2026 18:40
Source
TradingKey
Simply Wall Street Direct company coverage

Assembly Biosciences (Nasdaq:ASMB) - Stock Analysis

This report provides a comprehensive stock analysis of Assembly Biosciences (ASMB), detailing its financial performance, future growth prospects, past performance, and risk factors. It highlights that ASMB is trading significantly below its estimated fair value with promising ear

Tone
Negative 39/100
Event
Market update
Published
23 Jun 2026 07:09
Source
Simply Wall Street
TradingKey Direct company coverage

Assembly Biosciences Inc (ASMB) Institutional Confidence

This article analyzes the institutional confidence in Assembly Biosciences Inc (ASMB), noting its current score of 5.00 within the Biotechnology & Medical Research industry. Institutional shareholding has increased significantly by 171.06% quarter-over-quarter, now standing at 58

Tone
Positive 66/100
Event
Market update
Published
18 Jun 2026 16:10
Source
TradingKey
TradingKey Direct company coverage

Assembly Biosciences Inc (ASMB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Assembly Biosciences Inc (ASMB), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 16th in the Biotechnology & Medical Research industry with a strong buy c

Tone
Positive 72/100
Event
Earnings
Published
18 Jun 2026 04:41
Source
TradingKey
TradingKey Direct company coverage

Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Assembly Biosciences Inc (ASMB), listing its major shareholders and their proportions, including Gilead Sciences Inc, Farallon Capital Management, and RA Capital Management. It also breaks down shareholder types such as hedge fund

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 21:09
Source
TradingKey
TradingKey Direct company coverage

Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Assembly Biosciences Inc (ASMB) focusing on its dividend and stock split history. It indicates that the company has not distributed dividends in the past five years and lists several stock merger events that occurred on February 8, 2024, with

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 21:09
Source
TradingKey
Moomoo Direct company coverage

Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating

Mizuho has increased its price target for Assembly Biosciences (ASMB) to $45 from $40, while maintaining an "Outperform" rating on the stock. This adjustment comes despite a report within the same article about Unity Software's Q4 earnings, which showed higher-than-expected reven

Tone
Positive 72/100
Event
Analyst action
Published
16 Jun 2026 03:09
Source
Moomoo
The Globe and Mail Direct company coverage

Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead

Assembly Biosciences highlighted its antiviral and liver disease development strategy, discussing upcoming decisions for its HSV-2 program with Gilead, the expansion of its hepatitis delta candidate into cholestatic liver diseases, and expected clinical data readouts. The company

Tone
Positive 73/100
Event
Market update
Published
09 Jun 2026 13:09
Source
The Globe and Mail
Stock Traders Daily Direct company coverage

(ASMB) Movement Within Algorithmic Entry Frameworks

This article from Stock Traders Daily analyzes Assembly Biosciences (ASMB) using AI models, identifying weak near- and mid-term sentiment but a strong long-term outlook. It provides specific algorithmic trading strategies—Long Position, Momentum Breakout, and Risk Hedging Short—a

Tone
Negative 38/100
Event
Guidance
Published
08 Jun 2026 14:48
Source
Stock Traders Daily
Stock Titan Direct company coverage

Assembly Biosciences (ASMB) CEO receives 50,750 RSUs in equity grant

Assembly Biosciences (ASMB) CEO and President Jason A. Okazaki received a grant of 50,750 Restricted Stock Units (RSUs) at no cash cost. This grant, approved on March 29, 2026, became issuable after stockholders approved an amendment to the company's 2018 Stock Incentive Plan on

Tone
Neutral 50/100
Event
Balance sheet
Published
06 Jun 2026 12:10
Source
Stock Titan
Stock Titan Direct company coverage

Assembly Biosciences (NASDAQ: ASMB) awards 8,000 stock options to director McHutchison

Assembly Biosciences (NASDAQ: ASMB) has granted 8,000 stock options to its director, John G. McHutchison. These options have an exercise price of $24.11 per share and are set to expire on June 4, 2036. The vesting of these options is contingent on continuous service and will occu

Tone
Neutral 50/100
Event
Market update
Published
06 Jun 2026 10:40
Source
Stock Titan
Stock Titan Direct company coverage

Assembly Biosciences (ASMB) CSO granted 14,000 RSUs tied to plan amendment

Assembly Biosciences' Chief Scientific Officer, William E. Delaney IV, was granted 14,000 Restricted Stock Units (RSUs), representing 35% of his annual equity award. This grant, made at no cash cost, was contingent on stockholder approval of an amendment to the company's 2018 Sto

Tone
Neutral 50/100
Event
Regulatory and legal
Published
06 Jun 2026 00:09
Source
Stock Titan